Orphan Diseases and public health
As the number of persons suffering from individual rare conditions is small, they don't constitute a significant request for medicine manufacturers to develop the orphan medicine and bring them to the request. For this reason, rare diseases are also called orphan diseases and medicines to treat them are called “orphan medicines”.
The charge of public health has been shortly stated as “The fulfilment of society’s interest in assuring conditions in which people can be healthy”. Public health specialist use a combination of disciplines that include introductory wisdom, clinical exploration, epidemiology, statistics, behavioural exploration, health care services, economics, and policy to identify the primary or secondary causes of health threats and also totally help, alleviate, or suppress these causes in entire world populations. This approach has been extensively successful against contagious conditions.
Related Conference of Orphan Diseases and public health
5th International conference on Vaccines, Vaccination and Immunization
19th International Conference on Allergy and Clinical Immunology
5th International Conference on Immunology And Immunotherapy
Orphan Diseases and public health Conference Speakers
Recommended Sessions
- Orphan medicinal products
- Advance therapies for rare diseases
- Clinical Research on Orphan Drugs
- Immunological Rare Diseases
- Infectious Diseases
- Orphan Diseases and public health
- Orphan Drugs
- Orphan Drugs and Potentiality
- Orphan drugs ethical issues
- Rare Autoimmune Diseases
- Rare Genetic Disorder
- Rare Gynaecological and Obstetrical Diseases
- Rare Mental and Behavioural Disorders
- Rare Obesity and Metabolic Disorders
- Rare Oncology
- Rare Skin Diseases
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)